How Stay22 went from pandemic freefall to one of Montréal tech’s biggest growth stories

How Stay22 went from pandemic freefall to one of Montréal tech’s biggest growth stories

Montréal-based travel content monetization startup Stay22 has completed a total turnaround since losing 90 percent of its revenue in 2020.  “It’s a great way to finally get a tap on the back.” Andrew Lockhead, Stay22 On Thursday, the 105-person startup announced it raised $122 million USD ($167 million CAD) in an all-equity, minority growth investment…

Read Full News
NordSpace launches venture arm with strategic investment in Wyvern

NordSpace launches venture arm with strategic investment in Wyvern

Canadian aerospace company NordSpace announced today the launch of NordSpace Ventures, a newly established division focused on investing in the space, defence, and dual-use technology sector. Its first portfolio member is an Edmonton space data company with one of the world’s most powerful satellite imaging arrays. Nordspace calls the investment an act of sovereignty-building between…

Read Full News
Single dose of DMT shows promise for treatment-resistant depression in early clinical trial

Single dose of DMT shows promise for treatment-resistant depression in early clinical trial

BY THE OPTIMIST DAILY EDITORIAL TEAM A single, carefully administered dose of the psychedelic compound dimethyltryptamine, better known as DMT, may offer meaningful relief for people living with treatment-resistant depression, according to results from a new clinical trial. In the small study, published in Nature Medicine, researchers found that when DMT was combined with structured…

Read Full News